Shigeki Arawaka

4.5k citations

81 papers · 2.7k indexed · h-index 31

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 23
- Neurological disorders and treatments 10
- Peripheral Neuropathies and Disorders 7
- Amyotrophic Lateral Sclerosis Research 6
Cellular and Molecular Neuroscience top 2%
- Nerve injury and regeneration 8
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 23
- Neurological disorders and treatments 10
- Peripheral Neuropathies and Disorders 7
- Amyotrophic Lateral Sclerosis Research 6
Physiology top 2%
- Alzheimer's disease research and treatments 17
Cell Biology top 5%
- Cellular transport and secretion 6
Epidemiology
- Inflammatory Myopathies and Dermatomyositis 6

Co-authors: Takeo Kato Shingo Koyama Hiroyasu Sato Manabu Wada Toru Kawanami Keiji Kurita Hiroshi Mori Peter St George‐Hyslop
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Journal of Biological Chemistry (6 papers)Journal of Neuroscience (2 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: Japan United States Canada

In The Last Decade

Shigeki Arawaka

77 papers receiving 2.6k citations

Peers

Countries citing papers authored by Shigeki Arawaka

Since Specialization

Citations

This map shows the geographic impact of Shigeki Arawaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Arawaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Arawaka more than expected).

Fields of papers citing papers by Shigeki Arawaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Arawaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Arawaka. The network helps show where Shigeki Arawaka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shigeki Arawaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shigeki Arawaka Line = papers co-authored together Shigeki Arawaka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Risk factors and outcome of hyponatremia in patients with Guillain–Barré syndrome Scientific Reports ·Shoji Ogawa,Takafumi Hosokawa,Chizuko Hayakawa,Taiki Sawai,Kensuke Kakiuchi,Daisuke Nishioka,Yukiyo Yoshimoto,Yuichi Masuda,Yoshitsugu Nakamura,Shin Ota,Shigeki Arawaka	2024	0
2	GRK5‐mediated inflammation and fibrosis exert cardioprotective effects during the acute phase of myocardial infarction FEBS Open Bio ·Akiomi Nagasaka,Tsuyoshi Terawaki,Makoto Noda,Miyuki Takashima,Mika Fujino,Yuto Yamauchi,Shigeki Arawaka,Takeo Kato,Michio Nakaya	2023	3
3	A case of anti-myelin oligodendrocyte glycoprotein antibody-positive multiphasic disseminated encephalomyelitis showing significant recovery after immunoadsorption plasmapheresis Rinsho Shinkeigaku ·Shoji Ogawa,Kensuke Kakiuchi,Takafumi Hosokawa,Maki Kagitani,Shimon Ishida,Shigeki Arawaka	2023	0
4	Spatial Fluctuation of Central Nervous System Lesions in X-linked Charcot-Marie-Tooth Disease with a Novel <i>GJB1</i> Mutation Internal Medicine ·Yukiyo Yoshimoto,Shoko Yoshimoto,Kensuke Kakiuchi,Rumina Miyagawa,Shin Ota,Takafumi Hosokawa,Shimon Ishida,Yujiro Higuchi,Akihiro Hashiguchi,Hiroshi Takashima,Shigeki Arawaka	2023	0
5	Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy Scientific Reports ·Akihiro Tsukahara,Takafumi Hosokawa,Daisuke Nishioka,Takuya Kotani,Shimon Ishida,Tohru Takeuchi,Fumiharu Kimura,Shigeki Arawaka	2021	10
6	Monoamine oxidase-B inhibition facilitates α-synuclein secretion in vitro and delays its aggregation in rAAV-based rat models of Parkinson’s disease Journal of Neuroscience ·Yoshitsugu Nakamura,Shigeki Arawaka,Hiroyasu Sato,Asuka Sasaki,Taro Shigekiyo,Kazue Takahata,Hiroko Tsunekawa,Takeo Kato	2021	12
7	Clinical features of Guillain–Barré syndrome patients with elevated serum creatine kinase levels BMC Neurology ·Takafumi Hosokawa,Hideto Nakajima,Taiki Sawai,Yoshitsugu Nakamura,Eri Sano,Akihiro Tsukahara,Kiichi Unoda,Shimon Ishida,Sadaki Sakane,Fumiharu Kimura,Shigeki Arawaka	2020	7
8	Preventive Effect of Cilostazol on Pneumonia in Patients with Acute Cerebral Infarction Journal of Stroke and Cerebrovascular Diseases ·Yoshitsugu Nakamura,Hideto Nakajima,Fumiharu Kimura,Kiichi Unoda,Shigeki Arawaka	2018	13
9	Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature Rheumatology International ·Shogo Matsuda,Shuzo Yoshida,Youhei Fujiki,Hidetoshi Satomi,Tohru Takeuchi,Yoshinobu Hirose,Shigeki Makino,Shigeki Arawaka	2017	7
10	Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates Acta Neuropathologica Communications ·Shigeki Arawaka,Hiroyasu Sato,Asuka Sasaki,Shingo Koyama,Takeo Kato	2017	85
11	Zonisamide Attenuates α-Synuclein Neurotoxicity by an Aggregation-Independent Mechanism in a Rat Model of Familial Parkinson’s Disease PLoS ONE ·Shigeki Arawaka,Shingo Fukushima,Hiroyasu Sato,Asuka Sasaki,Kaori Koga,Shingo Koyama,Takeo Kato	2014	10
12	Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein–coupled receptor kinase–dependent manner Molecular Biology of the Cell ·Susumu Hara,Shigeki Arawaka,Hiroyasu Sato,Youhei Machiya,Can Cui,Asuka Sasaki,Shingo Koyama,Takeo Kato	2013	43
13	Carpal tunnel syndrome as an initial manifestation in a case of transthyretin-related familial amyloid polyneuropathy with a novel A120T mutation Clinical Neurology and Neurosurgery ·Shingo Koyama,Toru Kawanami,K Kurokawa,H. Tanji,Chifumi Iseki,Shigeki Arawaka,Manabu Wada,Takeo Kato	2011	4
14	N‐terminal region of α‐synuclein is essential for the fatty acid‐induced oligomerization of the molecules FEBS Letters ·Hiroki Karube,Masahiro Sakamoto,Shigeki Arawaka,Susumu Hara,Hiroyasu Sato,Chang-Hong Ren,Saori Goto,Shingo Koyama,Manabu Wada,Toru Kawanami,Keiji Kurita,Takeo Kato	2008	45
15	Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis Experimental Neurology ·Chang-Hong Ren,Manabu Wada,Shingo Koyama,Hideki Kimura,Shigeki Arawaka,Toru Kawanami,Keiji Kurita,Toshihiko Kadoya,Masashi Aoki,Yasuto Itoyama,Takeo Kato	2005	49
16	An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick’s disease Biochemical and Biophysical Research Communications ·Kenji Kikuchi,Shigeki Arawaka,Shingo Koyama,Hideki Kimura,Chang-Hong Ren,Manabu Wada,Toru Kawanami,Keiji Kurita,Makoto Daimon,Shinobu Kawakatsu,Toshihiko Kadoya,Kaoru Goto,Takeo Kato	2003	24
17	Presenilin 1 and Presenilin 2 Have Differential Effects on the Stability and Maturation of Nicastrin in Mammalian Brain Journal of Biological Chemistry ·Fusheng Chen,Anurag Tandon,Nobuo Sanjo,Yongjun Gu,Hiroshi Hasegawa,Shigeki Arawaka,Frank J.S. Lee,Xueying Ruan,Peter Mastrangelo,Serap Erdebil,Linda Wang,David Westaway,Howard T.J. Mount,Bruce A. Yankner,Paul E. Fraser,Peter St George‐Hyslop	2003	32
18	The levels of mature glycosylated nicastrin are regulated and correlate with γ‐secretase processing of amyloid β‐precursor protein Journal of Neurochemistry ·Shigeki Arawaka,Hiroshi Hasegawa,Anurag Tandon,Christopher Janus,Fusheng Chen,Gang Yu,Kenji Kikuchi,Shingo Koyama,Takeo Kato,Paul E. Fraser,Peter St George‐Hyslop	2002	34
19	Presenilin structure, function and role in Alzheimer disease Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Paul E. Fraser,Dun-Sheng Yang,Gang Yu,Lyne Lévesque,Masaki Nishimura,Shigeki Arawaka,Louise C. Serpell,Ekaterina Rogaeva,Peter St George‐Hyslop	2000	74
20	Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome Neurology ·Utako Nagaoka,Tsuyoshi Kato,K. Kurita,Shigeki Arawaka,Takamitsu Hosoya,Nobuhiro Yuki,Yusuke Shikama,Kumiko Yamaguchi,Hidenao Sasaki	1996	30

About Shigeki Arawaka

Shigeki Arawaka is a scholar working on Neurology, Cellular and Molecular Neuroscience and Rheumatology, having authored 81 papers that have together received 2.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (23 papers), Alzheimer's disease research and treatments (17 papers), Neurological disorders and treatments (10 papers), Nerve injury and regeneration (8 papers), Peripheral Neuropathies and Disorders (7 papers), Amyotrophic Lateral Sclerosis Research (6 papers), Inflammatory Myopathies and Dermatomyositis (6 papers) and Cellular transport and secretion (6 papers). The work is most often cited by research in Neurology (1.1k citations), Cellular and Molecular Neuroscience (744 citations) and Neurology (324 citations). Shigeki Arawaka has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Takeo Kato, Shingo Koyama, Hiroyasu Sato, Manabu Wada, Toru Kawanami, Keiji Kurita, Hiroshi Mori, Peter St George‐Hyslop, Makoto Daimon and Hiroshi Takuma. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact